|Day Low/High||1.85 / 2.12|
|52 Wk Low/High||1.01 / 5.15|
Stocks with insider trader activity include VLGEA, LLTC and ALIM
The most recent short interest data has been released by the NASDAQ for the 01/29/2016 settlement date, which shows a 314,613 share increase in total short interest for Alimera Sciences, Inc. , to 2,422,062, an increase of 14.93% since 01/15/2016.
The most recent short interest data has been released by the NASDAQ for the 01/15/2016 settlement date, which shows a 261,657 share increase in total short interest for Alimera Sciences, Inc. , to 2,107,449, an increase of 14.18% since 12/31/2015.
The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 387,663 share decrease in total short interest for Alimera Sciences, Inc. , to 1,845,792, a decrease of 17.36% since 12/15/2015.
The CMS reimbursement code for ILUVIEN® is expected to ease and speed insurance payments
Data presented as Late Breaking Development during Retina Subspecialty Day at AAO 2015
Dan Myers, CEO, will join leading innovators in ophthalmology to discuss ILUVIEN® and advancements in the industry
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Alimera Sciences, Inc. , where a total volume of 12,500 contracts has been traded thus far today, a contract volume which is representative of approximately 1.2 million underlying shares (given that every 1 contract represents 100 underlying shares).
Interest only repayment period extended up to 18 months
Insiders at these companies have been scooping up shares of their own stock lately.
These stocks trading for less than $10 a share are within range of triggering breakout trades.
Paper highlights 28 cases in the United Kingdom and Germany
Interim six-month data confirms ILUVIEN was well tolerated and effective in reducing retinal thickness and increasing best corrected visual acuity